Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.
A study led by researchers at Yale School of Medicine showed that an inhalation treatment based on thyroid hormone can significantly reverse lung scarring (fibrosis) in mice models of pulmonary fibrosis and ... Read more
A former American football player’s foundation is teaming up with AffloVest to provide one of the company’s airway-clearing devices to a cystic fibrosis patient in each of the 50 states. The partners are ... Read more
Researchers in Boston and Toronto have discovered another molecular mechanism involved in lung scarring. The team at Massachusetts General Hospital and Toronto’s University Health Network said scientists might be able to develop a ... Read more
New York City’s Montefiore Einstein Center for Heart & Vascular Care has received interim approval from the United Network for Organ Sharing (UNOS) to launch its new lung transplant program. Lung transplant ... Read more
A retrospective real-world study found that the benefits of Esbriet (pirfenidone) in people with advanced idiopathic pulmonary fibrosis (IPF) appeared to diminish after six months of treatment, although side effects were ... Read more
The U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib), by Genentech, as a front-line treatment for people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). Results from ... Read more